FFCP PHASE2:Hg19::chr5:37371163..37371231,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@NUP155 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_NUP155_5end |
Coexpression cluster: | C4496_oral_chronic_small_Hep2_cervical_choriocarcinoma_synovial |
Association with transcript: | 0bp_to_ENST00000434056, ENST00000507675, ENST00000513532, NM_153485, uc003jku.1, uc010iuz.1_5end |
EntrezGene: | NUP155 |
HGNC: | 8063 |
UniProt: | B4DLT2D6RA13E9PF10O75694 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@NUP155 |
---|
0
50
100
150
200
250
300
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 6.20e-60 | 235 |
disease of cellular proliferation | 4.48e-57 | 239 |
cell type cancer | 4.22e-39 | 143 |
carcinoma | 4.74e-32 | 106 |
organ system cancer | 4.04e-23 | 137 |
hematologic cancer | 3.02e-15 | 51 |
immune system cancer | 3.02e-15 | 51 |
leukemia | 9.58e-13 | 39 |
myeloid leukemia | 1.51e-10 | 31 |
disease of anatomical entity | 2.02e-07 | 39 |
Showing 1 to 10 of 10 entries